Electrocore, INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
NASDAQ
ECOR
Electrocore, INCelectroCore reports increased 2025 revenue driven by prescription products and general wellness offerings, alongside continued net losses and a CEO retirement, raising going concern doubts.
NASDAQ
ECOR
Electrocore, INCelectroCore's 2024 10-K filing reveals a significant revenue increase driven by key products and strategic partnerships, while also addressing ongoing risks and regulatory challenges.
NASDAQ
ECOR
Electrocore, INCElectroCore, Inc.'s annual 10-K filing outlines its share structure, voting rights, anti-takeover provisions, and regulatory compliance, while also highlighting financial risks and future strategies.